Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M606169200 on October 24, 2006

J. Biol. Chem., Vol. 282, Issue 1, 454-466, January 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/1/454    most recent
M606169200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiao, H.
Right arrow Articles by Chen, W.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, H.
Right arrow Articles by Chen, W.-F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F*

Huan Qiao{ddagger}12, Luisa Di Stefano§13, Chan Tian{ddagger}, Yun-Yan Li{ddagger}, Yan-Hui Yin{ddagger}, Xiao-Ping Qian{ddagger}, Xue-Wen Pang{ddagger}, Yan Li{ddagger}, Michael Allen McNutt, Kristian Helin§4, Yu Zhang{ddagger}5, and Wei-Feng Chen{ddagger}6

From the Departments of {ddagger}Immunology and Pathology, Peking University Health Science Center, Beijing 100083, China and the §Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy

The two known DP proteins, TFDP1 and -2, bind E2Fs to form heterodimers essential for high affinity DNA binding and efficient transcriptional activation/repression. Here we report the identification of a new member of the DP family, human TFDP3. Despite the high degree of sequence similarity, TFDP3 is apparently distinct from TFDP1 in function. Although TFDP3 retained the capacity to bind to E2F proteins, the resulting heterodimers failed to interact with the E2F consensus sequence. In contrast to the stimulatory effect of TFDP1, TFDP3 inhibited E2F-mediated transcriptional activation. Consistent with this observation, we found that ectopic expression of TFDP3 impaired cell cycle progression from G1 to S phase instead of facilitating such a transition as TFDP1 does. Sequence substitution analysis indicated that the DNA binding domain of TFDP3 was primarily responsible for the lack of DNA binding ability of E2F-TFDP3 heterodimers and the inhibition of E2F-mediated transcriptional activation. Fine mapping further revealed four amino acids in this region, which were critical for the functional conversion from activation by TFDP1 to suppression by TFDP3. In conclusion, these studies identify a new DP protein and a novel mechanism whereby E2F function is regulated.


Received for publication, June 28, 2006 , and in revised form, August 28, 2006.

* This work was supported by National Natural Science Foundation of China Grant 30531160045, National 863 Program in China Grant 2003AA215110, National Basic Research Program of China Grant 2006CB504300, and Beijing Natural Science Foundation Grant 7061003. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These two authors contributed equally to this work.

2 Present address: Dept. of Medicine, Vanderbilt University School of Medicine, 2215 Garland Ave., 539 Light Hall, Nashville, TN 37232-0275.

3 Present address: Massachusetts General Hospital Cancer Center, Bldg. 149, 13th St., Charlestown, MA 02129.

4 Present address: BRIC, University of Copenhagen, Copenhagen 2100, Denmark.

5 To whom correspondence may be addressed: Dept. of Immunology, Peking University Health Science Center, 38 Xue Yuan Rd., Beijing 100083, China. Tel.: 86-10-82802593; Fax: 86-10-82801436; E-mail: zhangyu007{at}hsc.pku.edu.cn. 6 To whom correspondence may be addressed: Dept. of Immunology, Peking University Health Science Center, 38 Xue Yuan Rd., Beijing 100083, China. Tel.: 86-10-82802593; Fax: 86-10-82801436; E-mail: wfchen{at}public.bta.net.cn.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Masuhiro, K. Kayama, A. Fukushima, K. Baba, M. Soutsu, Y. Kamiya, M. Gotoh, N. Yamaguchi, and S. Hanazawa
SOCS-3 Inhibits E2F/DP-1 Transcriptional Activity and Cell Cycle Progression via Interaction with DP-1
J. Biol. Chem., November 14, 2008; 283(46): 31575 - 31583.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. R Mtango and K. E Latham
Differential Expression of Cell Cycle Genes in Rhesus Monkey Oocytes and Embryos of Different Developmental Potentials
Biol Reprod, February 1, 2008; 78(2): 254 - 266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement